The Autorité des Marchés Financiers (AMF) has issued a warning regarding fraudulent Forex investments on the LIVAXXEN platform, which continues to attract complaints despite being blacklisted. The AMF made this announcement in a news release dated January 13, 2025.
According to the AMF, the LIVAXXEN trading platform was added to its Forex blacklist on October 7, 2024. Despite this action, the authority continues to receive numerous complaints from retail investors about the platform’s alleged fraudulent practices. These include aggressive marketing tactics and demands for large fees when investors attempt to withdraw funds. The platform offers high leverage for trading across various global markets but is not authorized to provide investment services within the European Union.
Only companies authorized in the EU can offer services such as Forex and index trading. LIVAXXEN is not permitted to operate in France or offer investment services in Europe. As a result, investors have reported significant financial losses, with an average loss of €25,000. The AMF is taking measures to halt LIVAXXEN’s unauthorized activities and advises retail investors against engaging with the platform.
LIVAXXEN presents itself as a trading platform providing access to international markets, including stocks, Forex, and crypto-assets. It claims to offer leverage up to 1:400, low commission fees, and advanced trading tools on its website.
The AMF is an independent public authority in France responsible for overseeing financial markets, market participants, and investment products. It aims to ensure that investors are well-informed and that markets function orderly. The AMF also participates in regulatory development at both European and international levels, focusing on areas such as sustainable finance and digital economic changes. It operates through two main bodies—the board and the enforcement committee—and works towards establishing consistent international standards in financial markets.
